Navigation Links
Falcon Genomics Awarded Patent for Innovative Cancer Test
Date:5/28/2009

Patent Covers High-throughput, Anchorage-independent Assay for Screening Compounds for Inhibition of Cancer Cell Growth.

PITTSBURGH, May 28 /PRNewswire/ -- Falcon Genomics, Inc. announced today that it has received U.S. Patent # 7,537,913 with claims covering the Company's Cancer BioChip System (CBCS) for the identification and validation of potential cancer targets in a high-throughput in vitro setting with great clinical translational potential.

The patent claims are supported by experimental validation with human breast cancer cells using Falcon Genomics' first-generation Cancer BioChip System (CBC-1). These results, recently presented at the 6th Annual Conference on Cancer Drugs Research and Development in Philadelphia, PA (February 19, 2009) represent the first reported use of high-throughput one-step delivery of silencing RNA (siRNA) into cells growing in an anchorage-independent manner with real-time evaluation of cell growth.

"Cancer is analogous to a physiological train-wreck. It only takes a small number of defective signals to trigger the multitudes of abnormal molecular profiles observed within cancer cells. Triggering molecules are the ones that must be targeted for therapy," said Dr. Rula Abbud-Antaki, President and Chief Scientific Officer of Falcon Genomics. "Our proprietary technology will provide personalized identification of cancer- initiating events, and formulation of efficient and accurate therapies."

According to Dr. Peter D. Mlynek, a patent attorney with the law firm of Eckert Seamans, the Cancer BioChip System is a unique and highly useful technology. "The U.S. Patent Office has found the claimed CBCS to be novel and non-obvious."

About Falcon Genomics, Inc.

Falcon Genomics, Inc. is a private Pittsburgh-based biotech company founded in August 2004. The goal of the company is to provide cutting edge technologies, including functional genomics, for the accurate diagnosis of cancer patients and the personalized formulation of therapeutic strategies. Falcon Genomics currently provides CBCS services for research and pharmaceutical institutions working at the forefront of cancer diagnostics and therapeutics.

For more information, please visit: www.falcongenomics.com


'/>"/>
SOURCE Falcon Genomics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Atlanta Falcons Physical Therapy Centers Set to Launch This Fall
2. FalconStor Software Inc. Founders Make Multi-Million Dollar Donation to North Shore-LIJ Health System for Asian Community Health Center in Flushing
3. Atlanta Falcons Linebacker Keith Brooking Prepares to Run for Something Better at ING Georgia Marathon
4. MessageSolution and FalconStor Deliver Turnkey Solution for Enterprise Archiving, DR, and High-Availability
5. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
6. Medco, LabCorp Strike Strategic Agreement for Research on Personalized Medicine and Pharmacogenomics
7. Virginia Commonwealth University to Study Genomics-Based Diagnostic Test:
8. NeoGenomics, Inc. Schedules its Q3 07 Earnings Conference Call For Wednesday, November 14, 2007 at 11:00 AM
9. NeoGenomics Announces Results for the 3rd Quarter 2007
10. Rosetta Genomics Strengthens Senior Management in Preparation for its First Commercial Launch of microRNA-Based Diagnostic Products in 2008
11. Rosetta Genomics to Webcast Panel Presentation at RBC Capital Markets 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... ... Global Healthcare Management’s 4th Annual Kids Fun Run brought out many kids ... sponsored by Global Healthcare Management’s CEO, Jon Letko, is aimed at getting kids excited ... all ages; it is a non-competitive, non-timed event, which is all about having fun ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and the ... published author, William Nowers. Captain Nowers and his wife, Millie, have six children, ... in the Navy. Following his career as a naval aviator and carrier pilot, ...
(Date:10/12/2017)... ... , ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s ... design of the shoulder pad. The shoulder pad provides optimal support and full ... while using cold therapy. By utilizing ice and water that is circulated from an ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
Breaking Medicine News(10 mins):
(Date:9/22/2017)... 22, 2017 AVACEN Medical (AVACEN) announced that ... successfully helping those with the widespread pain associated with ... Amanda in Essex, England commented, ... hair, experiencing no sleep at all, tremendous pain, with ... cannot recommend [the AVACEN 100] enough, how this has ...
(Date:9/19/2017)... 2017   ZirMed Inc ., a recognized leader in ... it has been ranked #1 by its users for the ... 2017 User Survey. ZirMed was recognized as the top-ranked end-to-end ... medical centers over 200 beds and holds one of the ... survey history. ...
(Date:9/18/2017)... Sept. 18, 2017 EpiVax, Inc. ... bioinformatics and immune engineering, today announced a ... A (H7N9) vaccine. ... seasonal influenza and presents a challenge for ... exposure to be effective. Using state-of-the-art bioinformatics and ...
Breaking Medicine Technology: